Delivery Order SPE2DR25D2014-SPE2DR26FA2C7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $28,553.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 16, 2025, with an ultimate completion date of January 8, 2026. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a $27,094.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $113,445.72 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Voranigo 40 mg tablets (30-count units) with a completion date of January 26, 2026. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $52,462.98 on December 1, 2025, for the supply of Voranigo 40 mg tablets (30-count packages). This firm fixed-price, competitively awarded contract (no set-aside designation) is scheduled for completion by December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) with a completion date of February 3, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $26,231.49 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 12, 2025, with an ultimate completion date of December 4, 2025, and utilizes no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $81,284.85 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on November 5, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2C7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) with a firm fixed-price structure. The contract is classified as a non-set-aside award, indicating it was competitively procured. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2031. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor to federal military and veteran healthcare systems through this expansive IDC vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal procurement portfolio demonstrates significant capability in fulfilling complex medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This specific delivery order for Voranigo tablets exemplifies the breadth of pharmaceutical products distributed through the contractor's established relationship with the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 1/11/26 |